Biotech With Multiple Orphan Drugs Is Quietly Opening Its Doors

A promising biotech developing treatments for rare childhood brain diseases is opening a new raise. Its lead drug has fast-track status, orphan designations, is nearing Phase 2 and backed by a Global Integrator.

Popular

Donald Trump Calls For Soros To Be Imprisoned: 'He's A Bad Guy'

President Trump has advocated for the imprisonment of billionaire Democratic donor George Soros.

Tucker Carlson Asks OpenAI CEO Sam Altman If He Ordered Employee's Murder

During an interview with OpenAI CEO Sam Altman, Tucker Carlson suggested Altman may have played a role in the death of former employee Suchir Balaji.

Rare Disease Biotech Offers Access Ahead of Key Milestone - Ad

This late-stage biotech is gearing up for Phase 2 trials with an FDA-designated orphan drug. It's already drawing comparisons to recent billion-dollar exits. Backed by a proven biotech incubator, it's now offering early access to its raise.

US To Set $5 Billion Critical Minerals Fund

US to launch $5 billion fund for critical minerals, in partnership with Orion Resource Partners and other investors. Aimed at reducing reliance on Chinese supply chains and securing long-term resources.

Is This Elon's Worst Nightmare? - Ad

Elon's empire looks doomed - crashing sales, lost tax credits, and media backlash. But behind the scenes, Tesla is about to unleash a breakthrough Forbes calls a "multi-trillion-dollar opportunity." It's not the end - it's the start of a 25,000% AI comeback.

Plunging Mortgage Rates Could Light Up These 9 Stocks

Mortgage rates are dropping at their fastest pace in nearly a year. Homebuilders, loan servicers and retailers could benefit.

Bitcoin, Ethereum, XRP Flat; Solana Rises: BTC Is On 'Knife's Edge,' Says Analytics Firm — Future Depends On This Level

Cryptocurrencies held steady while stocks hit fresh highs on Wednesday, as a downward revision to jobs data lowered optimism but strengthened expectations for rate cuts.

The Tesla Shock Nobody Sees Coming - Ad

While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as October 23rd.

Trump's Immigration Policies Could 'Shrink' GDP Growth As US Population Projected To Decline, Warns CBO

The U.S. population growth is expected to decline at a faster rate than previously projected due to President Donald Trump's immigration policies, according to the Congressional Budget Office (CBO).

Elon's $25 Trillion Confession - Ad

Elon Musk: "Tesla will become a $25 trillion company." That would make Tesla 8x bigger than Apple today. How is that possible? He admits it's all thanks to this one AI breakthrough that will take AI out of our computer screens and manifest a 250x boom here in the real world.

Meta Unveils $499 Oakley Vanguard And $799 Ray-Ban Display Smart Glasses At Connect 2025: Gene Munster Says 'Best Bang For The Buck'

Meta unveiled its $499 Oakley Vanguard and $799 Ray-Ban Display smart glasses at Connect 2025, with Gene Munster calling the Ray-Ban model the "best bang for the buck" as competition with Apple heats up.

Why Trump's "Smart Dollar" Could Rewrite the Rules - Ad

Congress just approved President Trump's latest plans for the dollar - and they're so bold that one central bank chair says we haven't seen anything like it in almost a century. Our Wall Street insider says it's the start of a once-in-a-lifetime investing opportunity, IF you act now.

Cracker Barrel suspends plans to remodel restaurants after logo blowup

Cracker Barrel said Tuesday it’s suspending remodels of its restaurants after criticism from many longtime fans.

Toyota and Hyundai recall more than 1.1 million vehicles for seat belt, panel display problems

Toyota and Hyundai are recalling a combined 1.1 million vehicles due to problems with the instrument panel displays and seat belts, U.S. auto regulators said Thursday.

Biotech With Multiple Orphan Drugs Is Quietly Opening Its Doors - Ad

A promising biotech developing treatments for rare childhood brain diseases is opening a new raise. Its lead drug has fast-track status, orphan designations, is nearing Phase 2 and backed by a Global Integrator.

Trump Trying To 'Take Over The Fed,' Says Elizabeth Warren: Turkey, Argentina And Nixon-Era Serve As Cautionary Tales, Warns Senator

Sen. Elizabeth Warren (D-Mass.) accused President Donald Trump of attempting to undermine the independence of the Federal Reserve, warning that such a move could spark inflation, driving up costs substantially for American families.

Boeing workers reject their latest contract offer, extending strike at three Midwest plants

Another contract proposal has been rejected by Boeing workers who now have been from three Midwest plants where military aircraft and weapons are developed.

[Revealed] Trump's Next AI Executive Orders? - Ad

A White House insider with direct ties to Trump's inner circle just revealed what he calls "Manhattan II" - a potential $2.2 trillion AI initiative set to launch as soon as Oct 15. He says this could mirror past U.S. projects that minted fortunes - with small firms soaring 5,000% to 10,000% over two decades. And now he's giving away his #1 stock pick for free before the deadline.

Charlie Kirk Killed In Utah Shooting, Drawing Bipartisan Condemnation

House Speaker Johnson condemned the act: "This is not who we are." As of Sept. 9, there have been 298 mass shootings in the U.S. for 2025.

Lennar Shares Are Trading Lower Friday: What's Going On?

Lennar shares are trading lower Friday after the company reported worse-than-expected third quarter financial results on Thursday after the market closed.

We've Seen This Before... and It Didn't End Well - Ad

Strange events are unfolding in the global financial system. A monetary reset dubbed the "Mar-a-Lago Accord" is quietly in motion, and the financial elite are already taking protective action. If history is any guide, you could lose up to 40% of your wealth in the next two years. Move your money before it's too late.

US To Impose $100,000 Annual Fee On H-1B Visas As Analysts Warn Trump Risks 'Taxing Away' America's Innovation Edge

The Trump administration's plan to impose a $100,000 annual fee on H-1B visas could reshape tech hiring, strain talent pipelines from India and China, and risk driving innovation overseas, analysts warn.

New York City's Wealthiest Neighborhoods Witness 60% Rent Surge Since Pandemic

House rental rates in some of the wealthiest neighborhoods of New York City have surged by over 60% since the COVID-19 pandemic began, putting even high-income earners in a tight spot.

New Biotech Offering Targets $426B Rare Disease Market - Ad

The rare disease drug space is growing fast-and so is investor interest. With exclusivity, pricing power and major M&A moves, the rare disease space is getting interesting. This company has the science and the experience.

Why GameStop Shares Are Spiking After-Hours

GameStop Corp. (NYSE:GME) shares surged 5.72% during after-hours trading to $24.94 following strong second-quarter earnings and a special dividend announcemen

The New Way to Use AI in the Stock Market... - Ad

A Wall Street legend just helped train our own proprietary AI system in the stock market (a project that took dozens of technology and finance experts, including one PhD astrophysicist, and $4 million in total research costs). In a multi-year backtest, this breakthrough beat stocks, bonds, gold... even Warren Buffett.

Bill Holdings Shares Soar On Elliott Management Stake: Is An Activist Battle Brewing?

Bill Holdings stock is trading higher with a new activist investor circling the company. Shareholders could find out if two activists are better than one.

Rare Disease Biotech Offers Access Ahead of Key Milestone - Ad

This late-stage biotech is gearing up for Phase 2 trials with an FDA-designated orphan drug. It's already drawing comparisons to recent billion-dollar exits. Backed by a proven biotech incubator, it's now offering early access to its raise.

How 4 key infrastructure projects centered in Italy will reshape the European travel map

MILAN (AP) — Workers will begin drilling and blasting open the first tunnel connecting Austria to Italy under the Brenner Pass through the Alps on Thursday, marking a major milestone in a series of ambitious European Union projects that will accelerate passenger train travel between metropolitan centers and shift freight off the roads and onto rails.

ASML Invests Billions In Nvidia-Backed Mistral AI To Power Next Era Of Semiconductors

ASML partners with Mistral AI to enhance semiconductor manufacturing with AI, investing 1.3 billion euros for 11% stake.

Is This Elon's Worst Nightmare? - Ad

Elon's empire looks doomed - crashing sales, lost tax credits, and media backlash. But behind the scenes, Tesla is about to unleash a breakthrough Forbes calls a "multi-trillion-dollar opportunity." It's not the end - it's the start of a 25,000% AI comeback.

US Treasury sanctions Sinaloa cartel faction Los Mayos in Mexico

MEXICO CITY (AP) — The U.S. Treasury Department on Thursday sanctioned members of a Sinaloa cartel faction known as Los Mayos, one of the groups that has tormented Sinaloa's capital in .

AppLovin Sees Stronger Non-Gaming Momentum As Expansion Accelerates

AppLovin (APP) is expanding beyond gaming, with strong non-gaming revenue growth driven by international expansion, referral program, and seasonal ad spend.

Recommended

Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.

Copyright activatrade.ca
Privacy Policy | Terms of Service